Vagus Nerve Stimulation Market by Product (Implantable VNS Devices and External VNS Devices), Application (Depression, Epilepsy, and Migraine), End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), and Biomaterial (Ceramics, Metallic, and Polymeric) – Global Opportunity Analysis and Industry Forecast, 2022-2029
Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/3968
Vagus nerve stimulation (VNS) therapy is designed to avoid seizures by sending consistent, mild pulses of electrical signals to the brain through the vagus nerve. These pulses are delivered by a device, which resembles a pacemaker. Vagus nerve is a part of the autonomic nervous system that controls involuntary functions of the body such as heart rate. It passes through the neck, which passes between the chest and abdomen to the lower part of the brain. VNS device is referred to as the “pacemaker of the brain,” and is placed under the skin on the chest wall. A wire runs from it to the vagus nerve in the neck. Vagus nerve stimulators are used in treatment of intractable epilepsy and treatment-resistant depression.
The report global vagus nerve stimulation market is segmented based on product, application, end user, biomaterial, and geography. On the basis of product, the market is bifurcated as implantable VNS devices and external VNS devices. By application, it is categorized into depression, epilepsy, and migraine. In terms of biomaterial, it is divided into ceramics, metallic, and polymerics. In terms of end user, it is classified into hospitals, ambulatory surgical centers (ASCS), and others. Regionally, the market is analyzed in North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, and NeuroPace Inc.
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global vagus nerve stimulation market.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities across the geographies.
- This report entails the detailed quantitative analysis of the current market and estimations from 2016 to 2023 to identify the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
- Region- and country-wise market conditions are comprehensively analyzed in the report.
Vagus Nerve Stimulation Market Key Segments:
- Implantable VNS Devices
- External VNS Devices
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3968
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.